Description

Armotraz 1mg – Trusted Anastrozole Therapy

Armotraz is a prescription-only medicine (POM) manufactured by Cipla Limited. The active ingredient is anastrozole 1mg. Anastrozole is a non-steroidal aromatase inhibitor, a medicine that reduces oestrogen production in postmenopausal women. Armotraz is bioequivalent to Arimidex, the widely recognised UK reference brand. Both medicines share the same active ingredient at equal strength. They work in exactly the same way.

Composition

Anastrozole 1 mg

Manufacturer

Cipla Limited

Expiry

Batch-specific; refer to packaging

Parameter	Armotraz (Cipla Limited)	Arimidex (Reference Brand)
Active Ingredient	Anastrozole	Anastrozole
Strength	1mg	1mg
Chemical Class	Non-steroidal aromatase inhibitor	Non-steroidal aromatase inhibitor
Therapeutic Effect	Reduces circulating oestrogen	Reduces circulating oestrogen

Mechanism of Action

Anastrozole blocks the aromatase enzyme, which converts androgens into oestrogen in postmenopausal women. Reduced oestrogen reduces the stimulation of hormone-receptor-positive cancer cells, slowing tumour growth and reducing the risk of recurrence.

Clinical Uses

Armotraz is indicated for postmenopausal women with:

• Early-stage hormone-receptor-positive breast cancer
• Locally advanced or metastatic breast cancer
• Adjuvant therapy following surgery, chemotherapy, or radiotherapy

Safety Information and Side Effects

Always consult a qualified UK healthcare professional before starting or changing treatment. Report any adverse reactions to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk.

Type	Side Effect	Details
Common Side Effects	Hot flushes	–
Common Side Effects	Joint pain	Arthralgia
Common Side Effects	Fatigue	–
Common Side Effects	Nausea	–
Common Side Effects	Sleep disturbances	–
Serious Side Effects — Seek Immediate Medical Help	Anaphylaxis	Severe allergic reaction
Serious Side Effects — Seek Immediate Medical Help	Sudden chest pain	–
Serious Side Effects — Seek Immediate Medical Help	Osteoporosis	Progressive bone weakening
Serious Side Effects — Seek Immediate Medical Help	Rapid symptom worsening	–

Safety Advice

Liver

Use with caution in liver dysfunction. Your doctor will review your dose if needed. Liver enzyme levels may be checked on a regular basis.

Kidney

Generally safe in mild to moderate renal impairment. Severe kidney dysfunction requires medical supervision and possible dose review.

Alcohol

Alcohol may worsen dizziness or nausea. Limit intake and consult your doctor regarding safe consumption.

Driving

Fatigue and dizziness are possible with Armotraz. Do not drive or use machinery until you understand how this medicine affects you.

Pregnancy

Armotraz should not be taken during pregnancy. There is a risk of harm to the developing foetus. This medicine is for postmenopausal women only.

Breastfeeding

Do not take whilst breastfeeding. Anastrozole may pass into breast milk and harm an infant.

Accessing Treatment Responsibly

In the UK, Armotraz is supplied only through a regulated pharmacy. A valid prescription is required to obtain it. Do not attempt to self-medicate with hormonal cancer treatments.

Frequently Asked Questions

Q: What is Armotraz used for?

A: In postmenopausal women, Armotraz lowers oestrogen levels. This helps to treat hormone-receptor-positive breast cancer. Treatment must take place under medical supervision.

Q: How long is treatment?

A: Duration is determined by your oncologist. Anastrozole is typically prescribed for several years as part of ongoing hormonal therapy.

Conclusion

Armotraz contains anastrozole 1mg, a clinically proven non-steroidal aromatase inhibitor bioequivalent to Arimidex. Take Armotraz strictly as your oncologist directs. Speak to a qualified UK healthcare professional before making any changes to your treatment.

References

• NHS UK: Anastrozole — https://www.nhs.uk/medicines/anastrozole/
• MHRA Yellow Card Scheme — https://yellowcard.mhra.gov.uk/

Medical Disclaimer

This content is intended for educational purposes only. It is not a substitute for medical advice. Before starting, stopping, or adjusting any medicine, always speak to a registered UK healthcare professional.